Motac Neuroscience Ltd

Motac provides highly-specialised preclinical research services for the pharmaceutical and biotechnology industries, to support the discovery and development of novel therapies for neurological and psychiatric disorders. This is enabled through our extensive expertise and world-class research capabilities in neurodegenerative conditions, particularly Parkinsons disease, other movement disorders and cognitive disorders. We specialize in preclinical proof-of-concept and efficacy studies. Motac has unparalleled ability to offer access to the best available models of these conditions, underpinned by first-class scientific understanding, in a commercial environment, with a strong emphasis on quality and timeliness. Motac personnel have published widely in the highest-quality, peer-reviewed, scientific journals...

Ad pd and other movement disorders

Motac neuroscience ltd operates in the Research services industry.

Motac neuroscience ltd's revenue is 11m - 100m

Motac neuroscience ltd has 11 - 50 employees.